Particle Dynamics Appoints New CFO as it Advances its Strategic Growth Plans

Industry veteran Mike Kanan has joined Particle Dynamics as the new Chief Financial Officer.

Mike brings more than 30 years’ strategic finance experience across the pharma, life sciences, and industrial sectors, including significant tenures at Avadel Pharmaceuticals and industry titan Sigma Aldrich, now part of Merck Group.

This addition to the Particle Dynamics leadership team will enhance operational efficiencies and drive strategic initiatives, including expanding and strengthening its global standing as a provider of GMP-quality oral solid dosage solutions.

ST. LOUIS–(BUSINESS WIRE)–Particle Dynamics, a leader in oral solid dosage (OSD) technologies for the pharmaceutical sector, has announced the appointment of industry veteran Mike Kanan as its new Chief Financial Officer. Mike’s appointment marks a significant milestone for Particle Dynamics, underscoring the company’s commitment to delivering enhanced value to clients and stakeholders.


With more than 30 years’ finance experience spanning private equity-owned and public companies including industry giant Sigma Aldrich, acquired by Merck KGaA in 2015, Mike brings a wealth of knowledge and expertise to his new role at Particle Dynamics. His proven track record in financial leadership and strategic planning will be instrumental in driving Particle Dynamics’ continued growth and success in the pharmaceutical and healthcare industries.

As well as overseeing the finance function, Mike will work with the executive team to develop and implement strategic initiatives aimed at enhancing operational efficiency and driving growth across the organization.

Nicolas Fortin, CEO of Particle Dynamics, said: “Mike’s extensive experience and financial leadership make him the ideal candidate to lead our finance team during this exciting period of growth and expansion. I am confident Mike’s strategic vision will be invaluable as we continue to strengthen our position as a global leader in particle processing and delivery technologies.”

In addition to his six years at Sigma Aldrich as Vice President of Finance and Corporate Controller, Mike served at Avadel Pharmaceuticals as Chief Financial Officer, a publicly traded specialty pharma company.

Mike added: “I look forward to working with the talented team at Particle Dynamics at a pivotal time in the company’s growth trajectory and collaborating with them to drive financial excellence, foster innovation, and deliver value to our customers and stakeholders.”

About Particle Dynamics

Particle Dynamics is a global leader in particle processing, delivery technologies and finished dose manufacturing for the nutraceutical, consumer health, OTC, and pharmaceutical sectors. The company provides a wide range of products and services, including formulation development, commercial manufacturing, API development, and packaging. Particle Dynamics has a proven track record of delivering high-quality GMP products and services that meet the needs of its customers. The company is committed to providing its customers with the highest level of customer service. Visit us at www.particledynamics.com

Contacts

Jen Gornet

Executive Coordinator

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.